A randomized phase 2 clinical trial of phentolamine mesylate eye drops in patients with severe night vision disturbances

Overview of attention for article published in BMC Ophthalmology, October 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#3 of 2,616)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 27 news outlets
twitter: 5 X users

patent: 2 patents

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 10 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 4,033 followers.

Driving with red eyes at night? “No officer I wasn’t drinking it’s my Nyxol” https://t.co/9cV2zHDlL8 “Out of the car” 👮‍♀️ $OCUP

04 Nov 2022

Reply Repost Favourite

$OCUP nyxol @GregLarssen Improvements in contrast sensitivity, visual acuity, patient-reported outcomes and decreases in wavefront aberrations all contribute to evidence of the potential benefits of PMOS for patients with Dim light vision disturbances. ht

02 Nov 2022

Reply Repost Favourite

RT @TomSChangMD: A randomized phase 2 clinical trial of phentolamine mesylate eye drops in patients with severe night vision disturbances h…

11 Oct 2022

Reply Repost Favourite

RT @TomSChangMD: A randomized phase 2 clinical trial of phentolamine mesylate eye drops in patients with severe night vision disturbances h…

11 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.